VANGUARD GROUP INC - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 232 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$26,168,855
-26.0%
29,535,954
+31.2%
0.00%0.0%
Q3 2022$35,351,000
-15.8%
22,516,574
+7.8%
0.00%0.0%
Q2 2022$42,002,000
+13.4%
20,896,424
+31.4%
0.00%0.0%
Q1 2022$37,051,000
-49.2%
15,901,385
+1.3%
0.00%
-50.0%
Q4 2021$72,971,000
-38.3%
15,692,730
+1.2%
0.00%
-33.3%
Q3 2021$118,314,000
-13.6%
15,506,493
+9.7%
0.00%0.0%
Q2 2021$136,920,000
+22.1%
14,129,991
+4.2%
0.00%0.0%
Q1 2021$112,096,000
+33.4%
13,554,519
+10.1%
0.00%
+50.0%
Q4 2020$84,015,000
-32.1%
12,309,867
+10.9%
0.00%
-50.0%
Q3 2020$123,793,000
+101.8%
11,102,479
+13.7%
0.00%
+100.0%
Q2 2020$61,344,000
+407.6%
9,768,037
+48.7%
0.00%
+100.0%
Q1 2020$12,085,000
-44.6%
6,567,699
+1.7%
0.00%0.0%
Q4 2019$21,824,000
+98.7%
6,456,695
+25.8%
0.00%
Q3 2019$10,986,000
-14.3%
5,134,044
+6.9%
0.00%
Q2 2019$12,819,000
-38.7%
4,801,332
+9.1%
0.00%
-100.0%
Q1 2019$20,914,000
+141.3%
4,402,843
+21.9%
0.00%
Q4 2018$8,668,000
-63.7%
3,611,682
-33.4%
0.00%
-100.0%
Q3 2018$23,856,000
-26.3%
5,421,877
+20.6%
0.00%0.0%
Q2 2018$32,373,000
+107.3%
4,496,335
+48.3%
0.00%0.0%
Q1 2018$15,620,000
+70.8%
3,032,934
+26.0%
0.00%
Q4 2017$9,145,000
+146.3%
2,406,461
+10.2%
0.00%
Q3 2017$3,713,000
-3.8%
2,184,065
+13.1%
0.00%
Q2 2017$3,861,000
-36.6%
1,930,524
+25.3%
0.00%
Q1 2017$6,088,000
-21.2%
1,541,266
-2.3%
0.00%
Q4 2016$7,727,000
-34.3%
1,577,017
+3.8%
0.00%
-100.0%
Q3 2016$11,763,000
+117.0%
1,519,720
+57.0%
0.00%
Q2 2016$5,420,000
-0.5%
967,923
-4.4%
0.00%
Q1 2016$5,447,000
-27.9%
1,012,452
+16.7%
0.00%
-100.0%
Q4 2015$7,553,000
+13.6%
867,224
+9.4%
0.00%
Q3 2015$6,649,000
-49.7%
792,500
+5.7%
0.00%
-100.0%
Q2 2015$13,212,000
+94.4%
749,822
+27.6%
0.00%
Q1 2015$6,795,000
+56.1%
587,814
+36.0%
0.00%
Q4 2014$4,352,000
+147.1%
432,210
+10.9%
0.00%
Q3 2014$1,761,000
-30.3%
389,592
+4.1%
0.00%
Q2 2014$2,526,000
+13.2%
374,201
+114.9%
0.00%
Q1 2014$2,232,000
+2407.9%
174,135
+1477.3%
0.00%
Q4 2013$89,00011,0400.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 2,799,790$11,059,0003.50%
Intellectus Partners, LLC 1,095,840$4,329,0002.20%
Cormorant Asset Management, LP 1,690,800$6,679,0000.97%
Avoro Capital Advisors LLC 1,192,130$4,709,0000.60%
Vident Investment Advisory, LLC 170,534$674,0000.07%
GAGNON SECURITIES LLC 11,116$44,0000.02%
MATRIX ASSET ADVISORS INC/NY 22,000$87,0000.02%
R&F Capital Advisors LP 12,878$51,0000.01%
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 96,154$380,0000.01%
Virtu KCG Holdings LLC 27,425$108,0000.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders